Clinical Trials and Results Public Disclosure
Amgen is committed to the timely communication of scientifically valid results, both positive and negative, from our clinical trials.

Global Code of Ethics for Clinical Trials
Amgen is committed to protecting the rights of clinical trial participants worldwide. 

Policy on the Support of US Clinical Practice and Treatment Guidelines
Amgen occasionally offers financial support to independent bodies who develop clinical and treatment guidelines.  Amgen does not exert any influence or control over the development of guidelines that it has funded.

Adverse Event Reporting
An “Adverse Event” is any new, undesirable medical experience or change in an existing condition which occurs during or after use of any marketed or investigational product.  Amgen staff are required to report Adverse Events within one business day.

Interactions with Healthcare Professionals and Other Customers
Amgen requires that all interactions with healthcare professionals and other customers comply with all applicable laws and adhere to the highest standards of professional ethics and responsibility.

Commitment to the Ethical Use of Animals in Research
Most regulating bodies, including the FDA, require that potential medicines be thoroughly tested in animals prior to human testing.  In our research, Amgen seeks to eliminate or reduce impact to animals, to provide high quality care to laboratory animals, and to use alternatives to animal research whenever possible.